Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer | NEJM - nejm.org

Original Article from The New England Journal of Medicine — Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

From the International Breast Cancer Center, Quirónsalud Group, Barcelona, the Scientific Department, Medica Scientia Innovation Research, Valencia, and the Department of Medicine, Faculty of Biomedi… [+2192 chars]

full article...